May 13, 2026
Chondroitin Sulfate Sourcing in 2026: What 240 Million Osteoarthritis Patients Mean For Supply
Osteoarthritis affects over 240 million people worldwide. And the number of people over 60 is set to double by 2050. Here's what that means for the chondroit...
-
![The Global Innovative Products Made Clinical Progress, And The Stc3141 China ...]()
Nov 01, 2022The Global Innovative Products Made Clinical Progress, And The Stc3141 China ...STC3141 is a global innovative small molecule compound with a new mechanism of action independently developed by Broad Medicine. This product can b...view more -
![What Are The Advantages Of Johnson & Johnson BCMA/CD3?]()
Oct 31, 2022What Are The Advantages Of Johnson & Johnson BCMA/CD3?On Oct. 25, the FDA approved Johnson & Johnson's BCMA/CD3 dual antibody Teclistamab for marketing in relapsed and refractory multiple myeloma (MM) ...view more -
![New Rheumatoid Arthritis (Ra) Drug! Glaxosmithkline Terminates The Anti-Gm-Cs...]()
Oct 31, 2022New Rheumatoid Arthritis (Ra) Drug! Glaxosmithkline Terminates The Anti-Gm-Cs...Otilimab is a monoclonal antibody targeting the granulocyte-macrophage colony-stimulating factor (GM-CSF), developed for the treatment of moderate ...view more -
![Late Cancer Will Have A Radical Cure Is Possible, The New Anti-Cancer Technol...]()
Oct 28, 2022Late Cancer Will Have A Radical Cure Is Possible, The New Anti-Cancer Technol...Researchers at Yale University and the University of Rhode Island recently made a new technological discovery that 18 of the 20 mice had completely...view more -
![Johnson & Johnson BCMA/CD3 Dual Antibody Approved For Marketing]()
Oct 28, 2022Johnson & Johnson BCMA/CD3 Dual Antibody Approved For MarketingJanssen, a subsidiary of Johnson & Johnson, recently announced that teclistamab, the world's first BCMA/CD3 bisspecificity antibody, has been appro...view more -
![The Explosive Power Of Small Nucleic Acid Was Initially Shown]()
Oct 27, 2022The Explosive Power Of Small Nucleic Acid Was Initially ShownIn the past two months, news events in the field of precise targeting of "small nucleic acids" have attracted considerable attention On September 3...view more -
![With Alpha, AI To Help Develop Innovative Drugs For Obesity]()
Oct 27, 2022With Alpha, AI To Help Develop Innovative Drugs For ObesityOn October 24, Xintai and Alpha molecule signed an agreement to jointly develop new drugs.view more -
![A New Round Of Health Care Negotiations Is Coming! The Price War Of 5 CDK4/6 ...]()
Oct 26, 2022A New Round Of Health Care Negotiations Is Coming! The Price War Of 5 CDK4/6 ...Recently (October 20), Hengrui Pharmaceutical Group 1 CDK4/6 inhibitor "Dalsilil doxylate tablets" submitted a class 2.4 marketing application was ...view more -
![25 Class 1 New Drugs Approved Clinical, A Number Of Domestic First New Drugs ...]()
Oct 25, 202225 Class 1 New Drugs Approved Clinical, A Number Of Domestic First New Drugs ...In this period, 54 new drug applications were granted default permission for clinical trials, involving 27 domestic new drugs and 9 imported new dr...view more -
![Carrelizumab Combination Therapy Is Proposed To Be Included in The Breakthrou...]()
Oct 25, 2022Carrelizumab Combination Therapy Is Proposed To Be Included in The Breakthrou...Hengrui Pharmaceutical issued a notice on October 23, saying: Recently, patients with recurrent or metastatic non-small cell lung cancer (NSCLC) wi...view more -
![The Current Hot! Hengrui Medicine Carilizumab Combination Therapy Is Planned ...]()
Oct 24, 2022The Current Hot! Hengrui Medicine Carilizumab Combination Therapy Is Planned ...Hengrui medicine announced on October 23, said: recently, Hengrui medicine innovative drug pearl single line treatment of tumor cells PD-L1 express...view more -
![Rise Of $10 Billion FGFR Market]()
Oct 24, 2022Rise Of $10 Billion FGFR MarketFGFR , fibroblast growth factor receptor (FGFR), is one of the most popular targets for "unlimited cancer" therapy. It is an important member of th...view more
